Search Results

There are 13879 results for: content related to: The first recombinant FVIII produced in human cells – an update on its clinical development programme

  1. Spotlight on the human factor: building a foundation for the future of haemophilia A management

    Haemophilia

    Volume 21, Issue s1, January 2015, Pages: 1–12, C. Kessler, J. Oldenburg, C. Escuriola Ettingshausen, A. Tiede, K. Khair, C. Négrier and R. Klamroth

    Version of Record online : 4 DEC 2014, DOI: 10.1111/hae.12582

  2. Achievements, challenges and unmet needs for haemophilia patients with inhibitors

    Haemophilia

    Volume 22, Issue S1, January 2016, Pages: 1–24, Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer, M. Soucie, S. Claeyssens, D.w. Scott, R. d'Oiron, G. Lavigne-Lissalde, G. Kenet, C. Escuriola Ettingshausen, A. Borel-Derlon, T. Lambert, G. Pasta and C. Négrier

    Version of Record online : 5 JAN 2016, DOI: 10.1111/hae.12860

  3. You have free access to this content
    Poster Presentations

    Haemophilia

    Volume 23, Issue S2, February 2017, Pages: 29–140,

    Version of Record online : 24 JAN 2017, DOI: 10.1111/hae.13150

  4. You have free access to this content
    Third Åland islands conference on von Willebrand disease, 26–28 September 2012: meeting report

    Haemophilia

    Volume 19, Issue s3, March 2013, Pages: 1–18, E. Berntorp, B. Fuchs, M. Makris, R. Montgomery, V. Flood, J. S. O'Donnell, A. B. Federici, D. Lillicrap, P. James, U. Budde, M. Morfini, P. Petrini, S. Austin, C. Kannicht, V. Jiménez-Yuste and C. Lee

    Version of Record online : 6 FEB 2013, DOI: 10.1111/hae.12078

  5. You have full text access to this OnlineOpen article
    PK-guided personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in adults with severe haemophilia A

    Haemophilia

    T. Lissitchkov, L. Rusen, P. Georgiev, J. Windyga, R. Klamroth, L. Gercheva, L. Nemes, A. Tiede, J. Bichler, S. Knaub, L. Belyanskaya, O. Walter and K. J. Pasi

    Version of Record online : 27 APR 2017, DOI: 10.1111/hae.13251

  6. You have full text access to this OnlineOpen article
    Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

    Haemophilia

    R. J. Liesner, M. Abashidze, O. Aleinikova, C. Altisent, M. J. Belletrutti, A. Borel-Derlon, M. Carcao, H. Chambost, A. K. C. Chan, L. Dubey, J. Ducore, N. A. Fouzia, M. Gattens, Y. Gruel, B. Guillet, N. Kavardakova, M. El Khorassani, A. Klukowska, T. Lambert, S. Lohade, M. Sigaud, V. Turea, J. K. M. Wu, V. Vdovin, A. Pavlova, M. Jansen, L. Belyanskaya, O. Walter, S. Knaub and E. J. Neufeld

    Version of Record online : 16 AUG 2017, DOI: 10.1111/hae.13320

  7. You have full text access to this OnlineOpen article
    Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq®) in children with severe haemophilia A: efficacy, safety and pharmacokinetics

    Haemophilia

    Volume 22, Issue 2, March 2016, Pages: 232–239, A. Klukowska, T. Szczepański, V. Vdovin, S. Knaub, M. Jansen and R. Liesner

    Version of Record online : 14 SEP 2015, DOI: 10.1111/hae.12797

  8. You have free access to this content
    Accepted Abstracts

    Haemophilia

    Volume 23, Issue S3, April 2017, Pages: 3–49,

    Version of Record online : 5 APR 2017, DOI: 10.1111/hae.13217

  9. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  10. You have free access to this content
    Abstracts

    Haemophilia

    Volume 22, Issue S4, July 2016, Pages: 3–138,

    Version of Record online : 11 JUL 2016, DOI: 10.1111/hae.12980

  11. You have full text access to this OnlineOpen article
    Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety

    Haemophilia

    Volume 22, Issue 2, March 2016, Pages: 225–231, T. Lissitchkov, K. Hampton, M. von Depka, C. Hay, S. Rangarajan, E. Tuddenham, K. Holstein, A. Huth-Kühne, I. Pabinger, S. Knaub, J. Bichler and J. Oldenburg

    Version of Record online : 28 AUG 2015, DOI: 10.1111/hae.12793

  12. You have full text access to this OnlineOpen article
    First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

    Haemophilia

    Volume 22, Issue 1, January 2016, Pages: 87–95, W. Kreuz, C. Escuriola Ettingshausen, V. Vdovin, N. Zozulya, O. Plyushch, P. Svirin, T. Andreeva, E. Bubanská, M. Campos, M. Benedik-Dolničar, V. Jiménez-Yuste, L. Kitanovski, A. Klukowska, A. Momot, N. Osmulskaya, M. Prieto, S. Z. Šalek, F. Velasco, A. Pavlova, J. Oldenburg, S. Knaub, M. Jansen, L. Belyanskaya, O. Walter and on behalf of the ObsITI study group and the ObsITI committee

    Version of Record online : 23 JUL 2015, DOI: 10.1111/hae.12774

  13. Poster Presentations

    Haemophilia

    Volume 22, Issue S2, February 2016, Pages: 19–111,

    Version of Record online : 17 JAN 2016, DOI: 10.1111/hae.1_12882

  14. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method

    Haemophilia

    Volume 21, Issue 6, November 2015, Pages: 837–845, A. Hillarp, K. D. Friedman, D. Adcock-Funk, S. Tiefenbacher, W. L. Nichols, D. Chen, M. Stadler and B. A. Schwartz

    Version of Record online : 14 JUL 2015, DOI: 10.1111/hae.12703

  15. Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: 771–776, C. Vézina, M. Carcao, C. Infante-Rivard, D. Lillicrap, A. M. Stain, E. Paradis, J. Teitel, G. E. Rivard and On the behalf ofthe Association of Hemophilia Clinic Directors of Canada and of the Canadian Association of Nurses in Hemophilia Care

    Version of Record online : 17 JUL 2014, DOI: 10.1111/hae.12479

  16. You have free access to this content
    New findings on inhibitor development: from registries to clinical studies

    Haemophilia

    Volume 23, Issue S1, January 2017, Pages: 4–13, F. Peyvandi, C. E. Ettingshausen, J. Goudemand, V. Jiménez-Yuste, E. Santagostino and M. Makris

    Version of Record online : 19 DEC 2016, DOI: 10.1111/hae.13137

  17. You have free access to this content
    Poster Presentation

    Haemophilia

    Volume 21, Issue S2, February 2015, Pages: 14–94,

    Version of Record online : 25 JAN 2015, DOI: 10.1111/hae.12625

  18. Allergic reaction in a cohort of haemophilia A patients using plasma-derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII

    Haemophilia

    Volume 21, Issue 4, July 2015, Pages: e281–e285, S. A. L. Montalvão, A. C. Tucunduva, L. H. Siqueira, A. L. A. Sambo, S. S. Medina and M. C. Ozelo

    Version of Record online : 30 APR 2015, DOI: 10.1111/hae.12647

  19. Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: 846–853, P. Batty, Y. -H. Chen, L. Bowles, D. P. Hart, S. Platton and K. J. Pasi

    Version of Record online : 7 AUG 2014, DOI: 10.1111/hae.12496

  20. You have full text access to this OnlineOpen article
    PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding

    Haemophilia

    M. Wang, J. B. Lawrence, D. V. Quon, J. Ducore, M. L. Simpson, L. N. Boggio, I. S. Mitchell, G. Yuan, W. A. Alexander and J.-F. Schved

    Version of Record online : 3 AUG 2017, DOI: 10.1111/hae.13301